SCHEMBL5375295

SCHEMBL5375295

Cc1ccc(Cc2ccc(=O)[nH]n2)cc1Oc1cccc(C#N)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.47
FNTA P49354 2/20 0.40
FNTB P49356 2/20 0.40
PGGT1B P53609 2/20 0.40
P2RX3 P56373 4/20 0.37
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
EPAS1 Q99814 1/20 0.37
AR P10275 1/20 0.36
MAP4K4 O95819 1/20 0.36
GSK3A P49840 1/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SLC22A12 Q96S37 1/20 0.34
LRRK2 Q5S007 1/20 0.34
IDH1 O75874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14570721 0.91 CYP3A4 (0.41) CYP3A4EPAS1CYP2C9CYP2C19SLC22A12
SCHEMBL5370543 0.89 CYP3A4 (0.46) CYP3A4FNTAFNTBPGGT1BP2RX3
SCHEMBL5364632 0.88 CYP3A4 (0.47) CYP3A4FNTAFNTBPGGT1BP2RX3
SCHEMBL5373746 0.88 KCNH2 (0.42) CYP3A4EPAS1CYP2C9CYP2C19SLC22A12
SCHEMBL5377579 0.88 CYP3A4 (0.52) CYP3A4FNTAFNTBPGGT1BP2RX3
SCHEMBL5370328 0.88 CYP3A4 (0.47) CYP3A4FNTAFNTBPGGT1BP2RX3
SCHEMBL5374410 0.88 CYP3A4 (0.49) CYP3A4FNTAFNTBPGGT1BP2RX3
SCHEMBL5371174 0.86 CYP3A4 (0.51) CYP3A4SLC22A12
SCHEMBL5386025 0.86 CYP3A4 (0.48) CYP3A4P2RX3EPAS1CYP2C9CYP2C19
SCHEMBL5377332 0.86 CYP3A4 (0.49) CYP3A4EPAS1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed